Abstract
Tracking genetic variations from positive SARS-CoV-2 samples yields crucial information about the number of variants circulating in an outbreak and the possible lines of transmission but sequencing every positive SARS-CoV-2 sample would be prohibitively costly for population-scale test and trace operations. Genotyping is a rapid, high-throughput and low-cost alternative for screening positive SARS-CoV-2 samples in many settings. We have designed a SNP identification pipeline to identify genetic variation using sequenced SARS-CoV-2 samples. Our pipeline identifies a minimal marker panel that can define distinct genotypes. To evaluate the system, we developed a genotyping panel to detect variants-identified from SARS-CoV-2 sequences surveyed between March and May 2020 and tested this on 50 stored qRT-PCR positive SARS-CoV-2 clinical samples that had been collected across the South West of the UK in April 2020. The 50 samples split into 15 distinct genotypes and there was a 61.9% probability that any two randomly chosen samples from our set of 50 would have a distinct genotype. In a high throughput laboratory, qRT-PCR positive samples pooled into 384-well plates could be screened with a marker panel at a cost of < £1.50 per sample. Our results demonstrate the usefulness of a SNP genotyping panel to provide a rapid, cost-effective, and reliable way to monitor SARS-CoV-2 variants circulating in an outbreak. Our analysis pipeline is publicly available and will allow for marker panels to be updated periodically as viral genotypes arise or disappear from circulation.
Funder
Wellcome Trust
Elizabeth Blackwell Institute, University of Bristol
Publisher
Public Library of Science (PLoS)
Reference15 articles.
1. Organisation WH. Timeline: WHO’s COVID-19 response 2020 [cited 2020 7/10]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline/].
2. An integrated national scale SARS-CoV-2 genomic surveillance network;Lancet Microbe. 2020
3. Data, disease and diplomacy: GISAID’s innovative contribution to global health;S Elbe;Glob Chall,2017
4. Direct RNA sequencing and early evolution of SARS-CoV-2;G Taiaroa;bioRxiv,2020
5. The coronavirus is mutating—does it matter?;E Callaway;Nature,2020
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献